D-0689-2021 Class III Terminated

Recalled by Teligent Pharma, Inc. — Buena, NJ

FDA drug recall D-0689-2021 was initiated by Teligent Pharma, Inc. on Jun 22, 2021 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications The recall status is terminated (terminated Jul 3, 2024). Affected quantity: 7872 tubes.

Recall details

Product Type
Drugs
Report Date
Jul 28, 2021
Initiation Date
Jun 22, 2021
Termination Date
Jul 3, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7872 tubes

Product description

Erythromycin Topical Solution USP, 2% 60 mL, Rx Only, Teligent Pharma, Inc., Buena, NJ 08310, NDC 52565-027-59

Reason for recall

Failed Impurities/Degradation Specifications

Distribution pattern

Nationwide

Code information

Lot 14180

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0689-2021
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0689-2021. Report a data issue: hello@regdatalab.com.